State Street Corp Blueprint Medicines Corp Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, State Street Corp holds 2,500,207 shares of BPMC stock, worth $222 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,500,207
Previous 2,765,702
9.6%
Holding current value
$222 Million
Previous $256 Million
14.72%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding BPMC
# of Institutions
379Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$601 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$590 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$504 Million0.06% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$173 Million0.44% of portfolio
-
Geode Capital Management, LLC Boston, MA1.49MShares$132 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.3B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...